AIMS: The CD36 gene encodes for a membrane receptor that facilitates fatty-acid uptake and utilization. Genetic variants of the CD36 gene have been associated with metabolic syndrome (MetS). We aimed to evaluate the association between the rs10499859A>G and rs13246513C>T polymorphisms and MetS components. METHODS: For this case-control study, 140 MetS and 187 normal subjects were randomly selected from the Tehran Lipid and Glucose Study participants. Biochemical and anthropometrical variables were measured. Genotyping for both single nucleotide polymorphisms (SNPs) was performed by polymerase chain reaction-restriction fragment length polymorphism. RESULTS: Case and control groups were not different in allele and genotype frequencies for these SNPs. However, the A and T alleles of these SNPs were significantly associated with elevated levels of high-density lipoprotein cholesterol (HDL-C) before age and sex adjustment (p=0.027 and 0.016, respectively). Association between the A allele and body mass index (BMI) was also significant after adjustment for MetS under the dominant model (p=0.009, β(2)=0.68). CONCLUSIONS: Based on our results, these polymorphisms do affect HDL-C level and BMI (MetS components), although the effect may be slight and restricted specifically to an environment-genotype.
AIMS: The CD36 gene encodes for a membrane receptor that facilitates fatty-acid uptake and utilization. Genetic variants of the CD36 gene have been associated with metabolic syndrome (MetS). We aimed to evaluate the association between the rs10499859A>G and rs13246513C>T polymorphisms and MetS components. METHODS: For this case-control study, 140 MetS and 187 normal subjects were randomly selected from the Tehran Lipid and Glucose Study participants. Biochemical and anthropometrical variables were measured. Genotyping for both single nucleotide polymorphisms (SNPs) was performed by polymerase chain reaction-restriction fragment length polymorphism. RESULTS: Case and control groups were not different in allele and genotype frequencies for these SNPs. However, the A and T alleles of these SNPs were significantly associated with elevated levels of high-density lipoprotein cholesterol (HDL-C) before age and sex adjustment (p=0.027 and 0.016, respectively). Association between the A allele and body mass index (BMI) was also significant after adjustment for MetS under the dominant model (p=0.009, β(2)=0.68). CONCLUSIONS: Based on our results, these polymorphisms do affect HDL-C level and BMI (MetS components), although the effect may be slight and restricted specifically to an environment-genotype.
Authors: Ping An; Barry I Freedman; Craig L Hanis; Yii-Der I Chen; Alan B Weder; Nicholas J Schork; Eric Boerwinkle; Michael A Province; Chao Agnes Hsiung; Xiaodong Wu; Thomas Quertermous; D C Rao Journal: Diabetes Date: 2005-03 Impact factor: 9.461
Authors: Steven J R Meex; Carla J H van der Kallen; Marleen M J van Greevenbroek; Petra M H Eurlings; Mohammed El Hasnaoui; Chris T A Evelo; Patrick J Lindsey; Joost J F P Luiken; Jan F C Glatz; Tjerk W A de Bruin Journal: FASEB J Date: 2005-10-11 Impact factor: 5.191
Authors: M Febbraio; N A Abumrad; D P Hajjar; K Sharma; W Cheng; S F Pearce; R L Silverstein Journal: J Biol Chem Date: 1999-07-02 Impact factor: 5.157
Authors: Alka Malhotra; Steven C Elbein; Maggie C Y Ng; Ravindranath Duggirala; Rector Arya; Giuseppina Imperatore; Adebowale Adeyemo; Toni I Pollin; Wen-Chi Hsueh; Juliana C N Chan; Charles Rotimi; Robert L Hanson; Sandra J Hasstedt; Johanna K Wolford Journal: Diabetes Date: 2007-03 Impact factor: 9.461
Authors: Shaista Malik; Nathan D Wong; Stanley S Franklin; Tripthi V Kamath; Gilbert J L'Italien; Jose R Pio; G Rhys Williams Journal: Circulation Date: 2004-08-23 Impact factor: 29.690
Authors: F Leprêtre; K J Linton; C Lacquemant; V Vatin; C Samson; C Dina; M Chikri; S Ali; P Scherer; K Séron; F Vasseur; T Aitman; P Froguel Journal: Diabetes Metab Date: 2004-11 Impact factor: 6.041